Related Experiment Video
Updated: Jan 31, 2026

Studying Interactions between Myeloid Cells and CAR T Cells In Vitro and In Vivo
Published on: July 25, 2025
Emerging Cell-Based Therapies for Systemic Sclerosis: From Stem Cells to CAR-T Cells
Vitaly Chasov1, Sabir Mukhametshin1, Elvina Gilyazova1
1Institute of Fundamental Medicine and Biology, Kazan Federal University, Kazan 420008, Russia.
Abstract:
Systemic sclerosis (SSc) is a disease in which malfunctioning immune cells lead to the formation of autoantibodies that damage blood vessels and body tissues. Fibrosis then develops in the affected organs. Its complex pathogenesis involves multiple immune and stromal cell types, soluble mediators, and dysregulated tissue repair, resulting in heterogeneous clinical manifestations and poor prognosis. Current disease-modifying therapies provide only modest benefits, often slowing but rarely reversing disease progression, and are associated with considerable adverse effects. These limitations have spurred the development of cell-based therapeutic strategies aimed at restoring immune tolerance and promoting tissue repair. In this review, we summarize recent advances in hematopoietic stem cell transplantation, mesenchymal stem cell therapy, and adoptive regulatory T cell transfer and highlight the emerging role of chimeric antigen receptor (CAR)-T cell therapy as a transformative approach for SSc. Collectively, these evolving strategies hold the potential to improve survival, achieve durable remissions, and significantly enhance quality of life for patients with SSc.
Insights
Systemic sclerosis (SSc) treatments are limited. New cell therapies like stem cell and CAR-T cell therapies show promise for immune tolerance and tissue repair in SSc patients.
Area of Science:
- Immunology and Rheumatology
- Cellular and Molecular Medicine
- Regenerative Medicine
Background:
- Systemic sclerosis (SSc) is an autoimmune disease characterized by immune cell dysfunction, autoantibody production, vascular damage, and progressive fibrosis in organs.
- The complex pathogenesis of SSc involves diverse immune and stromal cells, mediators, and aberrant tissue repair, leading to varied clinical presentations and poor outcomes.
- Current therapies for SSc offer limited efficacy, often only slowing progression and causing adverse effects, necessitating novel therapeutic approaches.
Purpose of the Study:
- To review recent advancements in cell-based therapeutic strategies for Systemic sclerosis.
- To explore the potential of hematopoietic stem cell transplantation, mesenchymal stem cell therapy, and regulatory T cell transfer.
- To highlight the emerging role of chimeric antigen receptor (CAR)-T cell therapy in treating SSc.
Main Methods:
- Review of current literature on cell-based therapies for Systemic sclerosis.
- Analysis of recent progress in hematopoietic stem cell transplantation (HSCT) and mesenchymal stem cell (MSC) therapy.
- Evaluation of adoptive regulatory T cell (Treg) transfer and chimeric antigen receptor (CAR)-T cell therapy applications in SSc.
Main Results:
- Hematopoietic stem cell transplantation, mesenchymal stem cell therapy, and adoptive regulatory T cell transfer are evolving strategies for SSc.
- Chimeric antigen receptor (CAR)-T cell therapy is emerging as a potentially transformative approach for SSc.
- These cell-based strategies aim to restore immune tolerance and enhance tissue repair mechanisms in SSc.
Conclusions:
- Cell-based therapies offer a promising avenue for treating Systemic sclerosis by addressing immune dysregulation and fibrosis.
- Emerging strategies like CAR-T cell therapy hold significant potential to revolutionize SSc treatment.
- These advanced therapeutic approaches may improve patient survival, achieve long-term remission, and enhance quality of life in SSc.
Related Concept Videos
Stem Cell Therapy for Tissue Regeneration
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
Adult Stem Cells
Embryonic Stem Cells
Embryonic Stem Cells
ES cells are grown in a culture medium where they can divide indefinitely, creating ES cell lines. Under certain conditions, ES cells can differentiate, either spontaneously into a variety of...
Induced Pluripotent Stem Cells
Distinctive Features of Adult Stem Cells vs Cancer Stem Cells
Adult stem cells
Adult stem cells are tissue-specific; hence, they divide to develop the tissue from which they originate. One type of adult stem cell is the epithelial stem cell, which gives rise to the keratinocytes in the multiple layers of epithelial cells in the epidermis of the skin. Adult bone marrow has three distinct types of stem cells:...

